• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Axogen (AXGN)

Common Shares
Sell: $15.86|Buy: $17.01|Change: 0.33 (2.04%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Address

13631 Progress Boulevard
Suite 400
Alachua
FL
USA
32615

Telephone

+1 888 2964361

Website

https://www.axogeninc.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Axogen Inc Annual Report for 20252026-02-26T00:00:00
Axogen Inc Fourth Quarter Earnings Conference Call for 20252026-02-25T08:00:00
Axogen Inc Fourth Quarter Earnings Results for 20252026-02-25T00:00:00
Axogen Inc Third Quarter Earnings Conference Call for 20252025-11-07T08:00:00
Axogen Inc Third Quarter Earnings Results for 20252025-11-07T00:00:00
Axogen Inc Second Quarter Earnings Conference Call for 20252025-08-08T08:00:00
Axogen Inc Second Quarter Earnings Results for 20252025-08-08T00:00:00
Axogen Inc Annual General Meeting for 20252025-06-05T08:00:00
Axogen Inc First Quarter Earnings Conference Call for 20252025-05-08T08:00:00
Axogen Inc First Quarter Earnings Result for 20252025-05-08T00:00:00

Previous key dates

NameKey Date
Axogen Inc. To Host Analyst & Investor Day2025-03-04T09:00:00
Axogen Inc Annual Report for 20242025-02-26T00:00:00
Axogen Inc Fourth Quarter Earnings Conference Call for 20242025-02-25T08:00:00
Axogen Inc Fourth Quarter Earnings Result for 20242025-02-25T00:00:00
Axogen Inc Third Quarter Earnings Conference Call for 20242024-11-07T08:00:00
Axogen Inc Third Quarter Earnings Result for 20242024-11-07T00:00:00
Axogen Inc Second Quarter Earnings Conference Call for 20242024-08-08T08:00:00
Axogen Inc Second Quarter Earnings Result for 20242024-08-08T00:00:00
Axogen Inc Annual General Meeting for 20242024-06-05T08:00:00
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference2024-05-29T15:40:00
Axogen Inc First Quarter Earnings Conference Call for 20242024-05-02T08:00:00
Axogen Inc First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.